Affordable Access

deepdyve-link
Publisher Website

Barrett's esophagus: proton pump inhibitors and chemoprevention II.

Authors
  • Richter, Joel E
  • Penagini, Roberto
  • Tenca, Andrea
  • Pohl, Daniel
  • Dvorak, Katerina
  • Goldman, Aaron
  • Savarino, Edoardo
  • Zentilin, Patrizia
  • Savarino, Vincenzo
  • Watson, Joshua T
  • Wong, Roy K H
  • Pace, Fabio
  • Casini, Valentina
  • Peura, David A
  • Herzig, Shoshana Joy
  • Kamiya, Takeshi
  • Pelosini, Iva
  • Scarpignato, Carmelo
  • Armstrong, David
  • DeVault, Kenneth R
  • And 8 more
Type
Published Article
Journal
Annals of the New York Academy of Sciences
Publisher
Wiley (Blackwell Publishing)
Publication Date
Sep 01, 2011
Volume
1232
Pages
114–139
Identifiers
DOI: 10.1111/j.1749-6632.2011.06048.x
PMID: 21950810
Source
Medline
License
Unknown

Abstract

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Report this publication

Statistics

Seen <100 times